Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 1, 1985
Clinical experience with the automatic implantable defibrillator
M Mirowski, P R Reid, M M Mower, et al.
Physical Review Letters
|
July 20, 2001
Transport processes in reversed-field-pinch plasmas: inconsistency with the self-organized-criticality paradigm
V Antoni, V Carbone, R Cavazzana, et al.
Current Medical Research and Opinion
|
August 25, 2004
Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe
Teddy Kosoglou, Paul Statkevich, Jean-Charles Fruchart, et al.
Journal of the American College of Cardiology
|
August 1, 1987
Pathologic findings related to the lead system and repeated defibrillations in patients with the automatic implantable cardioverter-defibrillator
I Singer, G M Hutchins, M Mirowski, et al.
European Heart Journal
|
April 26, 2003
Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia
R H Knopp, H Gitter, T Truitt, et al.
Circulation
|
April 30, 2003
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial
Christie M Ballantyne, John Houri, Alberto Notarbartolo, et al.
The Review of Scientific Instruments
|
March 6, 2014
First negative ion beam measurement by the Short-Time Retractable Instrumented Kalorimeter Experiment (STRIKE)
G Serianni, M De Muri, A Muraro, et al.
Lancet (London, England)
|
July 6, 1996
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol
A L Waldo, A J Camm, H deRuyter, et al.
The American Journal of Cardiology
|
April 29, 1998
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?
C M Pratt, A J Camm, W Cooper, et al.
British Journal of Clinical Pharmacology
|
September 19, 2002
Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin
Teddy Kosoglou, Ingo Meyer, Enrico P Veltri, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 1, 1985
Clinical experience with the automatic implantable defibrillator
M Mirowski, P R Reid, M M Mower, et al.
Physical Review Letters
|
July 20, 2001
Transport processes in reversed-field-pinch plasmas: inconsistency with the self-organized-criticality paradigm
V Antoni, V Carbone, R Cavazzana, et al.
Current Medical Research and Opinion
|
August 25, 2004
Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe
Teddy Kosoglou, Paul Statkevich, Jean-Charles Fruchart, et al.
Journal of the American College of Cardiology
|
August 1, 1987
Pathologic findings related to the lead system and repeated defibrillations in patients with the automatic implantable cardioverter-defibrillator
I Singer, G M Hutchins, M Mirowski, et al.
European Heart Journal
|
April 26, 2003
Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia
R H Knopp, H Gitter, T Truitt, et al.
Circulation
|
April 30, 2003
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial
Christie M Ballantyne, John Houri, Alberto Notarbartolo, et al.
The Review of Scientific Instruments
|
March 6, 2014
First negative ion beam measurement by the Short-Time Retractable Instrumented Kalorimeter Experiment (STRIKE)
G Serianni, M De Muri, A Muraro, et al.
Lancet (London, England)
|
July 6, 1996
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol
A L Waldo, A J Camm, H deRuyter, et al.
The American Journal of Cardiology
|
April 29, 1998
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?
C M Pratt, A J Camm, W Cooper, et al.
British Journal of Clinical Pharmacology
|
September 19, 2002
Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin
Teddy Kosoglou, Ingo Meyer, Enrico P Veltri, et al.
Page
of 11